em-100
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Mar 9, 2018 (NCT03489941)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- em-100
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03489941 | Phase 3 | Mar 9, 2018 | Eton Pharmaceuticals, Inc., LEH Pharma, ORA, Inc. |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Eton Pharmaceuticals, Inc. | For profit | 1 | 0 | 1 | 2018 |
| LEH Pharma | For profit | 1 | 1 | 1 | 2018 |
| ORA, Inc. | For profit | 1 | 0 | 1 | 2018 |
3 organizations
Page 1 / 1